Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Seaport, Hemab chart courses for $180M IPOs to fund depression, clotting candidates

Seaport, Hemab chart courses for $180M IPOs to fund depression, clotting candidates

  • April 27, 2026

Both Seaport and Hemab are hoping to bring in around $180 million each from their public listings this week, in the latest sign that biotech IPOs are regaining their momentum.

Leave A Comment

Fields (*) Mark are Required